Program length (60 minutes)
- Welcome and Introduction
- Rationale for and Approaches to Gene Therapy
- Understanding the Different Approaches to Gene Therapy and the Associated Challenges
- Discussion and Audience Question and Answer Session
Date / Time
Richard S. Finkel, MD
Chief of Division of Neurology
Nemours Children’s Hospital
Professor of Neurology
University of Central Florida College of Medicine in Orlando, Florida
KATHRYN WAGNER, MD
Professor of Neurology
Johns Hopkins School of Medicine
Director, Center for Genetic Muscle Disorders
Kennedy Krieger Institute
The goal of this activity is to improve the knowledge and competence of learners in the rationale and the use of gene therapy approaches for patients with muscular dystrophies.
This program is intended for pediatricians, pediatric neuromuscular specialists, general neuromuscular specialists, nurse practitioners, nurses, and other healthcare providers who care for patients with muscular dystrophy.
Upon completion of this activity, participants should be able to:
- Describe the rationale for gene therapy based on the underlying molecular basis of different muscular dystrophies
- Discuss the mechanisms of gene therapy
- Assess recent evidence on approved and emerging therapies for muscular dystrophy
- Cite the challenges associated with gene therapy approaches to treating and curing muscular dystrophies
Joint Accreditation Statement
In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Physician Continuing Medical Education
CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any relevant conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.